Stay updated on Pembrolizumab/Gemcitabine in ABC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Gemcitabine in ABC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an adjustment in the number of evaluable patients needed in the trial from 53 to 53, with the possibility of stopping early due to lack of response.
    Difference
    0.1%
    Check dated 2024-06-06T14:30:27.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria 6' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' which now includes examples such as a person's general health condition or prior treatments, and provides a link for general information about clinical research.
    Difference
    33%
    Check dated 2024-05-22T21:14:24.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-04-30T22:47:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Gemcitabine in ABC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.